Detalhe da pesquisa
1.
Patient-reported cutaneous signs and symptoms of adult pityriasis rubra pilaris and correlation with quality of life and clinician-reported severity: A cross-sectional study.
J Am Acad Dermatol
; 90(1): 200-202, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37748557
2.
Guselkumab for Pityriasis Rubra Pilaris and Dysregulation of IL-23/IL-17 and NFkB Signaling: A Nonrandomized Trial.
JAMA Dermatol
; 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38598229
3.
Recalcitrant Pyoderma Gangrenosum: Clinical Burden and Unmet Needs.
Clin Cosmet Investig Dermatol
; 16: 2143-2152, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37581011
4.
The individual Pityriasis Rubra Pilaris area and severity index (iPRPASI): validity, reliability, and responsiveness of a novel patient-reported severity tool.
Arch Dermatol Res
; 315(10): 2933-2935, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37532946
5.
New onset delusional infestation following abrupt cessation of hydroxyzine.
JAAD Case Rep
; 39: 51-52, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37583834
6.
Treatment of Topical Corticosteroid Withdrawal: A Case Series.
Dermatitis
; 2023 Dec 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38150554
7.
Pityriasis Rubra Pilaris Transcriptomics Implicate T Helper 17 Signaling and Correlate with Response to Ixekizumab, with Distinct Gene Expression Profiles in Nonresponders.
J Invest Dermatol
; 143(3): 501-504.e1, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36167251
8.
Rosacea changes during pregnancy: a single-center retrospective survey study.
Int J Womens Dermatol
; 9(4): e113, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37927369